BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Imai K, Yamashita YI, Nakao Y, Matsumoto T, Kinoshita S, Yusa T, Kitano Y, Kaida T, Hayashi H, Baba H. Is Portal Vein Embolization Followed by Hepatectomy for Hepatocellular Carcinoma Justified in Patients with Impaired Liver Function? Ann Surg Oncol 2021;28:854-62. [PMID: 32740735 DOI: 10.1245/s10434-020-08960-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Imai K, Baba H. ASO Author Reflections: Portal Vein Embolization Followed by Hepatectomy for Hepatocellular Carcinoma in Patients with Impaired Liver Function: Is It Justified? Ann Surg Oncol 2020;27:876-7. [PMID: 32761334 DOI: 10.1245/s10434-020-08985-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Taketomi A. Hepatic Resection for Hepatocellular Carcinoma in the Era of Molecular-targeted Agents and Immune Checkpoint Inhibitors in Japan. JMA J 2021;4:241-5. [PMID: 34414318 DOI: 10.31662/jmaj.2021-0035] [Reference Citation Analysis]
3 Beppu T, Yamamura K, Okabe H, Imai K, Hayashi H. Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma. Ann Gastroenterol Surg 2021;5:287-95. [PMID: 34095718 DOI: 10.1002/ags3.12414] [Reference Citation Analysis]
4 Baba H, Kanda M, Kodera Y, Fujii T. ASO Author Reflections: Expression and Malignant Potential of B4GALNT4 in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2020;27:3257-8. [PMID: 32277319 DOI: 10.1245/s10434-020-08458-x] [Reference Citation Analysis]
5 Imai K, Miyamoto Y, Tamura Y, Hayashi H, Ikeda O, Yamashita YI, Baba H. Simultaneous Portal Vein Embolization and Colorectal Resection in a Hybrid Interventional Radiology/Operating Suite for Synchronous Colorectal Liver Metastases. J Gastrointest Surg 2022. [PMID: 34997464 DOI: 10.1007/s11605-021-05212-w] [Reference Citation Analysis]